Hoppe C - Search Results

1

Virtual reality as complementary pain therapy in hospitalized patients with sickle cell disease.

Agrawal AK, Robertson S, Litwin L, Tringale E, Treadwell M, Hoppe C, Marsh A. Agrawal AK, et al. Among authors: hoppe c. Pediatr Blood Cancer. 2019 Feb;66(2):e27525. doi: 10.1002/pbc.27525. Epub 2018 Oct 26. Pediatr Blood Cancer. 2019. PMID: 30362236 Clinical Trial.

2

Renal medullary carcinoma in an adolescent with sickle cell anemia.

Marsh A, Golden C, Hoppe C, Quirolo K, Vichinsky E. Marsh A, et al. Among authors: hoppe c. Pediatr Blood Cancer. 2014 Mar;61(3):567. doi: 10.1002/pbc.24795. Epub 2013 Sep 24. Pediatr Blood Cancer. 2014. PMID: 24108577 No abstract available.

3

Microparticles as biomarkers of osteonecrosis of the hip in sickle cell disease.

Marsh A, Schiffelers R, Kuypers F, Larkin S, Gildengorin G, van Solinge W, Hoppe C. Marsh A, et al. Among authors: hoppe c. Br J Haematol. 2015 Jan;168(1):135-8. doi: 10.1111/bjh.13110. Epub 2014 Sep 6. Br J Haematol. 2015. PMID: 25196812 Free PMC article.

4

Adjuvant low-dose ketamine for paediatric and young adult sickle cell vaso-occlusive episodes in the emergency department.

Cooper-Sood JB, Hagar W, Marsh A, Hoppe C, Agrawal AK. Cooper-Sood JB, et al. Among authors: hoppe c. Br J Haematol. 2022 Jul;198(1):207-209. doi: 10.1111/bjh.18201. Epub 2022 Apr 9. Br J Haematol. 2022. PMID: 35396855 No abstract available.

5

Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.

Hoppe CC, Styles L, Heath LE, Zhou C, Jakubowski JA, Winters KJ, Brown PB, Rees DC, Heeney MM. Hoppe CC, et al. Pediatr Blood Cancer. 2016 Feb;63(2):299-305. doi: 10.1002/pbc.25771. Epub 2015 Sep 24. Pediatr Blood Cancer. 2016. PMID: 26402148 Clinical Trial.

6

Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease.

Hoppe C, Vichinsky E, Quirolo K, van Warmerdam J, Allen K, Styles L. Hoppe C, et al. J Pediatr Hematol Oncol. 2000 Jul-Aug;22(4):330-4. doi: 10.1097/00043426-200007000-00009. J Pediatr Hematol Oncol. 2000. PMID: 10959903 Clinical Trial.

7

Successful utilization of an electronic pain diary in a multinational phase 3 interventional study of pediatric sickle cell anemia.

Heath LE, Heeney MM, Hoppe CC, Adjei S, Agbenyega T, Badr M, Masera N, Zhou C, Brown PB, Jakubowski JA, Dampier C. Heath LE, et al. Among authors: hoppe cc. Clin Trials. 2017 Dec;14(6):563-571. doi: 10.1177/1740774517723307. Epub 2017 Jul 26. Clin Trials. 2017. PMID: 28743191 Clinical Trial.

8

Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial.

Hoppe C, Jacob E, Styles L, Kuypers F, Larkin S, Vichinsky E. Hoppe C, et al. Br J Haematol. 2017 May;177(4):620-629. doi: 10.1111/bjh.14580. Epub 2017 Mar 28. Br J Haematol. 2017. PMID: 28369718 Free PMC article. Clinical Trial.

9

Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experience.

Winstead M, Sun PP, Martin K, Earl J, Neumayr L, Hoppe C, Vichinsky E. Winstead M, et al. Among authors: hoppe c. Pediatr Hematol Oncol. 2017 Mar;34(2):100-106. doi: 10.1080/08880018.2017.1313917. Epub 2017 May 22. Pediatr Hematol Oncol. 2017. PMID: 28532265 Clinical Trial.

10

The natural history of sickle cell disease.

Hoppe C, Styles L, Vichinsky E. Hoppe C, et al. Curr Opin Pediatr. 1998 Feb;10(1):49-52. doi: 10.1097/00008480-199802000-00010. Curr Opin Pediatr. 1998. PMID: 9529638 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

331 results

Search Page